Skip to search formSkip to main contentSkip to account menu

MTC-220

National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

DipeptidesPaclitaxel
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
The elimination of MTC-220, a novel anti-tumor agent of conjugate of paclitaxel and muramyl dipeptide analogue, in rats
PurposeMTC-220, a conjugate of paclitaxel and muramyl dipeptide analogue, was reported to exhibit anti-tumor ability and anti… 
2012
2012
Analysis and Identification of the Impurities of Antineoplastic Agent MTC-220 by LC-MS/MS
OBJECTIVE:To analyze and identify the structures of the impurities in antine oplastic agent MTC-220. METH-ODS:LC-MS/MS method was… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)